Skip to content
Open access

In-Silico and In-Vitro Evaluation of Polyherbal Formulation for Anticancer Activity Against Non-Small Cell Lung Cancer

Oct 2026 · International journal of allied medical sciences and clinical research · 0 citations

Abstract

Background: Non-small cell lung cancer (NSCLC) remains a major cause of cancer-related mortality. Plant-derived constituents are being investigated as sources of compounds with potential effects on cancer-cell viability and migration. This study evaluated a combined methanolic leaf extract prepared from Azadirachta indica, Ficus racemosa and Aegle marmelos (AFAE) using phytochemical screening, thin-layer chromatography (TLC), molecular docking and in-vitro assays. Methods: Leaves were collected and authenticated, shade-dried, powdered and extracted using methanol by Soxhlet extraction. The combined extract was screened for major phytochemical groups and analysed by TLC. Quercetin was docked against fibroblast growth factor receptor 4 (FGFR4; reported PDB ID 5JKG) using CB-Dock 2/AutoDock Vina-based scoring. Cytotoxicity in A549 lung adenocarcinoma cells was assessed by MTT assay after 48 h. Cell migration was assessed by scratch/wound-healing assay, and cellular morphology was examined using acridine orange/ethidium bromide (AO/EtBr) staining. Results: Phenols, tannins, glycosides and quinones were strongly detected (+++); flavonoids were moderately detected (++); coumarins, alkaloids and saponins were detected at lower qualitative levels (+). The TLC profile indicated flavonoid/phenolic constituents. Quercetin showed a docking score of −7.9 kcal/mol, compared with −8.4 kcal/mol for fisogatinib. AFAE reduced A549 cell viability in a concentration-dependent manner, from 98.45% at 12.5 µg/mL to approximately 19.66% at 200 µg/mL, with a reported IC₅₀ of 119.21 µg/mL. At 48 h, wound closure was 78.31% in controls and 61.95% and 62.77% at 20 and 40 µg/mL, respectively. AO/EtBr staining showed changes consistent with apoptosis and membrane-compromised cell death. Conclusion: The findings provide preliminary in-vitro and computational evidence of cytotoxic and antimigratory activity of AFAE against A549 cells. The formulation requires further chemical standardisation, mechanistic validation, toxicity testing and in-vivo evaluation before any therapeutic conclusions can be drawn.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.